INDV

Indivior Pharmaceuticals, Inc. Common Stock

35.37

USD

+0.12

+0.34%

Oct 30, 15:59 UTC -4

Closed

After-Market

35.83

+0.46

+1.30%

Indivior Pharmaceuticals, Inc. Common Stock (INDV) Earnings

INDV Earnings Reports

Positive Surprise Ratio

INDV beat 16 of 23 last estimates.

70%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Indivior Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Oct 29, 2026, INDV reported earnings of 1.32 USD per share (EPS) for Q3 26, beating the estimate of 1.14 USD, resulting in a 15.65% surprise. Revenue reached 356.00 million, compared to an expected 335.94 million, with a 5.97% difference. The market reacted with a +1.38% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Oct 29, 2026 For Q2 27

Estimate

$46.66

Actual

$80.55

Surprise

+72.64%

OmniAb, Inc. Common Stock

Report Date

Oct 30, 2026 For Q3 26

Estimate

-$0.12

Actual

-$0.12

Surprise

+3.54%

FAQ

What were Indivior Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Indivior Pharmaceuticals, Inc. Common Stock reported EPS of $1.32, beating estimates by 15.65%, and revenue of $356.00M, 5.97% above expectations.

How did the market react to Indivior Pharmaceuticals, Inc. Common Stock's Q3 2026 earnings?

The stock price moved up 1.38%, changed from $34.77 before the earnings release to $35.25 the day after.

When is Indivior Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Indivior Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on -- analysts, Indivior Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.